Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device

BACKGROUND: The optimal strategy of peri-procedural anticoagulation in patients undergoing permanent cardiac device implantation is controversial. Our objective was to compare the major bleeding and thromboembolic complications in patients managed with uninterrupted warfarin (UW) vs. interrupted dab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diagn Ther
Main Authors: Madan, Shivanshu, Muthusamy, Purushothaman, Mowers, Katie L., Elmouchi, Darryl A., Finta, Bohuslav, Gauri, Andre J., Woelfel, Alan K., Fritz, Timothy D., Davis, Alan T., Chalfoun, Nagib T.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731585/
https://ncbi.nlm.nih.gov/pubmed/26885486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-3652.2015.10.06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados